Results 151 to 160 of about 214,460 (382)

Patient‐Centred Care in AD Was Discussed at a Meeting in Doha Organized by the International Society of Atopic Dermatitis

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT A pre‐meeting on the Organization of Care in Atopic Dermatitis was held on October 24, 2024, in Doha, Qatar, in the context of the 14th Georg Rajka Symposium on Atopic Dermatitis organized by the International Society of Atopic Dermatitis (ISAD).
J.‐F. Stalder   +15 more
wiley   +1 more source

Useful Instruments for Psoriasis Patients’ Follow‐Up in Teleconsultation Setting

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Background Teledermatology may be beneficial for psoriasis management and a working group of the International Psoriasis Council recently outlined the value of patient questionnaires in teledermatology. Objectives Identify instruments that could optimise psoriasis evaluation when completed before a teleconsultation; assess patients’ and ...
Emmanuel Mahé   +8 more
wiley   +1 more source

Knowledge and Awareness Among Patients with Chronic Kidney Disease Stage 3 [PDF]

open access: yes, 2016
Knowledge is a prerequisite for changing behavior, and is useful for improving outcomes and reducing mortality rates in patients diagnosed with chronic kidney disease (CKD).
Bartlett Ellis, Rebecca J.   +8 more
core  

Health‐Related Quality of Life in Stevens‐Johnson Syndrome and Toxic Epidermal Necrolysis: A Qualitative Study

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Background Epidermal necrolysis (EN), including Stevens‐Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN), are severe cutaneous drug reactions with high morbidity. However, the quality of life (QoL) impact during acute hospitalization is not well understood.
Jacob McFeeters   +9 more
wiley   +1 more source

Clinically Meaningful Improvements in Quality of Life, Including Sleep, With Two‐Week and Monthly Dosed Rademikibart: A Phase 2 Randomized Trial in Adults With Moderate‐to‐Severe Atopic Dermatitis

open access: yesJEADV Clinical Practice, EarlyView.
Rademikibart, a potent IL‐4Rα‐targeting antibody, achieved its primary endpoint as a treatment for adults with moderate‐to‐severe atopic dermatitis (AD) in the CBP‐201‐WW001 Phase 2 trial. There is a need for AD treatment options with convenient dosing intervals.
Jonathan I. Silverberg   +2 more
wiley   +1 more source

PRIDE Complex (Papulopustules and/or Paronychia, Regulatory Abnormalities of Hair Growth, Itching, Dryness Due to EGFR Inhibitors)

open access: yes
JEADV Clinical Practice, EarlyView.
Sweta Subhadarshani   +3 more
wiley   +1 more source

Prevalence and Burden of Somatic Symptom Disorder in Atopic Dermatitis and Chronic Pruritus—The Persistent Somatic Symptoms Across Diseases: Pruritus (SOMA.PRU) Study

open access: yesJEADV Clinical Practice, EarlyView.
In adults with atopic dermatitis and chronic pruritus, the mental comorbidity of Somatic Symptom Disorder is associated with higher average and worst pruritus intensity, higher psychological distress and lower quality of life. Additionally, there were nonsignificant changes in cutaneous nerve fiber densities in skin biopsies.
Stefan M. Kahnert   +13 more
wiley   +1 more source

The Crease Scale Sign as a Diagnostic Aid in Tinea Manuum

open access: yes
JEADV Clinical Practice, EarlyView.
Sunil Jaiswal   +3 more
wiley   +1 more source

Patient Characteristics, Disease Profile and Treatment Patterns in Mild and Moderate Psoriasis Patients: Results From Real‐World Clinical Practices in Five European Countries (PROSPECT Study)

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Background Categorisation of psoriasis (PsO) disease severity in patients varies, although body surface area (BSA) affected is commonly used (< 3% ‘mild’, 3%–10% ‘moderate’ and > 10% ‘severe’). While moderate‐severe PsO has been well‐studied, more limited information regarding mild‐to‐moderate PsO is available.
Emily Goddard   +6 more
wiley   +1 more source

Patient‐Reported Outcomes Selected by Paediatric Patients With Atopic Dermatitis in the Aiming High in Eczema/Atopic Dermatitis Approach

open access: yesJEADV Clinical Practice, EarlyView.
We surveyed 290 paediatric patients with atopic dermatitis (AD)/their caregivers to determine troublesome AD features described as PROs. The most selected were itch (0‐ to 5‐year‐old children: 85%; children aged ≥ 6 years: 89.3%), skin appearance/condition (69.9% and 61.6%, respectively), and sleep disturbance (38.1% and 25.4%, respectively ...
Yuji Fujita   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy